Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the […]
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the […]
